Biotherapeutics Cell Line Development Market to Reach Valuation of ~US$ 224 Mn by 2030
Biotherapeutics Cell Line Development Market to Reach Valuation of ~US$ 224 Mn by 2030
Stay updated with breaking news from Solentim Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biotherapeutics Cell Line Development Market to Reach Valuation of ~US$ 224 Mn by 2030
Biotherapeutics Cell Line Development Market to Reach Valuation of ~US$ 224 Mn by 2030
Launch of ICON™ and STUDIUS™ – New Products for an Integrated Cell Line Development Workflow, Upcoming Webinar Hosted by Xtalks Share Article In this free webinar, the featured speakers from Solentim and Galvanize Bio will discuss how data is driving a new workflow for cell line development. They will outline the transparency of clone selection and decision-making during cell line development, as well as integration of automation and software in biotherapeutics. Be the first to learn about two major new products from Solentim in this webinar. Clonality, and the gathering of quality evid...